drugset / Trial / NCT01284439
Hydroxypropylmethylcellulose 0.3% and Sodium Hyaluronate 0.18% for Ocular Surface Disease in Glaucoma
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To study effect of hydroxypropylmethylcellulose 0.3% and sodium hyaluronate 0.18% in the treatment of ocular surface disease in glaucoma patients.
Timeline
- Start
- 2011-01
- Primary completion
- 2012-01
- Completion
- 2012-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sodium Hyaluronate | Other / unclassified | — | — |
| Subject | hydroxypropylmethylcellulose | Unknown | — | — |